This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Multi-country Post-Marketing Observational Study o...
Clinical trial

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira�) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Read time: 1 mins
Last updated:16th Nov 2011
There is a need to evaluate the current diagnostic and treatment practices in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) in Central and Eastern European Countries, with special focus on the use of conventional disease modifying antirheumatic drugs (DMARDs) and biologic agents. Further, it is necessary to establish the long-term clinical outcomes of adalimumab therapy in routine clinical practice, in particular its sustained effectiveness, impact on extra-articular manifestations (EAMs), co-medication with Nonsteroidal anti-inflammatory drugs (NSAIDs) and work productivity.
Category Value
Study start date 2011-11-16

View full details